Melanoma is a type of cancer that originates from melanocytes, the cells responsible for producing skin pigment, and is known ...

Key mechanism of resistance to BRAF-targeted melanoma therapy discovered. Potential for developing new cancer therapies with high efficacy by regulating polyamine biosynthesis to suppress resistance.

Anchor] Melanoma, a type of skin cancer, has a mortality rate of more than 70%, but anticancer drugs currently used in ...

Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced the first patient ...

gordonii releases a substance called ornithine that prompts F. nucleatum to produce a molecule called polyamine in larger quantities. Since F. nucleatum requires methionine to produce polyamine, this ...